BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 19482507)

  • 1. Considering TWEAK as a target for therapy in renal and vascular injury.
    Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
    Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
    Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK, a multifunctional cytokine in kidney injury.
    Sanz AB; Sanchez-Niño MD; Ortiz A
    Kidney Int; 2011 Oct; 80(7):708-18. PubMed ID: 21697814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK/Fn14 pathway: a nonredundant role in intestinal damage in mice through a TWEAK/intestinal epithelial cell axis.
    Dohi T; Borodovsky A; Wu P; Shearstone JR; Kawashima R; Runkel L; Rajman L; Dong X; Scott ML; Michaelson JS; Jakubowski A; Burkly LC
    Gastroenterology; 2009 Mar; 136(3):912-23. PubMed ID: 19109961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TWEAKing tissue remodeling by a multifunctional cytokine: role of TWEAK/Fn14 pathway in health and disease.
    Burkly LC; Michaelson JS; Hahm K; Jakubowski A; Zheng TS
    Cytokine; 2007 Oct; 40(1):1-16. PubMed ID: 17981048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of TWEAK/Fn14 interaction in the synovial inflammation of RA.
    Kamijo S; Nakajima A; Kamata K; Kurosawa H; Yagita H; Okumura K
    Rheumatology (Oxford); 2008 Apr; 47(4):442-50. PubMed ID: 18310134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TWEAK and Fn14: new molecular targets for cancer therapy?
    Winkles JA; Tran NL; Berens ME
    Cancer Lett; 2006 Apr; 235(1):11-7. PubMed ID: 15885893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK induces liver progenitor cell proliferation.
    Jakubowski A; Ambrose C; Parr M; Lincecum JM; Wang MZ; Zheng TS; Browning B; Michaelson JS; Baetscher M; Wang B; Bissell DM; Burkly LC
    J Clin Invest; 2005 Sep; 115(9):2330-40. PubMed ID: 16110324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour necrosis factor-like weak inducer of apoptosis (TWEAK) and its receptor Fn14 during cardiac remodelling in rats.
    Mustonen E; Säkkinen H; Tokola H; Isopoussu E; Aro J; Leskinen H; Ruskoaho H; Rysä J
    Acta Physiol (Oxf); 2010 May; 199(1):11-22. PubMed ID: 20082609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine cooperation in renal tubular cell injury: the role of TWEAK.
    Justo P; Sanz AB; Sanchez-Niño MD; Winkles JA; Lorz C; Egido J; Ortiz A
    Kidney Int; 2006 Nov; 70(10):1750-8. PubMed ID: 17003819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
    Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
    Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular characterization of cytokine TWEAK and its receptor Fn14 in pig (Sus scrofa).
    Shui Y; Guan ZB; Zhang SQ
    Vet Immunol Immunopathol; 2008 Dec; 126(3-4):396-402. PubMed ID: 18817982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HMGB1 expression and secretion are increased via TWEAK-Fn14 interaction in atherosclerotic plaques and cultured monocytes.
    Moreno JA; Sastre C; Madrigal-Matute J; Muñoz-García B; Ortega L; Burkly LC; Egido J; Martín-Ventura JL; Blanco-Colio LM
    Arterioscler Thromb Vasc Biol; 2013 Mar; 33(3):612-20. PubMed ID: 23288170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tweak induces mammary epithelial branching morphogenesis.
    Michaelson JS; Cho S; Browning B; Zheng TS; Lincecum JM; Wang MZ; Hsu YM; Burkly LC
    Oncogene; 2005 Apr; 24(16):2613-24. PubMed ID: 15735761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the cytokine TWEAK and its receptor Fn14 in ischemic stroke.
    Inta I; Frauenknecht K; Dörr H; Kohlhof P; Rabsilber T; Auffarth GU; Burkly L; Mittelbronn M; Hahm K; Sommer C; Schwaninger M
    J Neurol Sci; 2008 Dec; 275(1-2):117-20. PubMed ID: 18793781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
    Burkly LC; Michaelson JS; Zheng TS
    Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TWEAK/Fn14 promotes apoptosis of human endometrial cancer cells via caspase pathway.
    Wang D; Fung JN; Tuo Y; Hu L; Chen C
    Cancer Lett; 2010 Aug; 294(1):91-100. PubMed ID: 20189297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
    Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
    Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAK/Fn14 interaction stimulates human bronchial epithelial cells to produce IL-8 and GM-CSF.
    Xu H; Okamoto A; Ichikawa J; Ando T; Tasaka K; Masuyama K; Ogawa H; Yagita H; Okumura K; Nakao A
    Biochem Biophys Res Commun; 2004 May; 318(2):422-7. PubMed ID: 15120617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.